CD4 and neoplasm: The tumor microenvironment is rich in molecules and several possible mechanisms may increase the number of FOXP3+ Tregs, such as driving CD4+ T-helper cells to develop into FOXP3+ Tregs, recruiting existing FOXP3+ Tregs to tumor sites, and inducing the expansion of retained Tregs.